Literature DB >> 21677023

The psychosocial and cognitive impact of longstanding 'benign' multiple sclerosis.

Ana-Luiza Sayao1, Anna-Marie Bueno, Virginia Devonshire, Helen Tremlett.   

Abstract

BACKGROUND: Benign multiple sclerosis (BMS) is typically defined using the Expanded Disability Status Scale (EDSS), which relies heavily on ambulation. We set out to examine important psychosocial and cognitive outcomes in patients with longstanding BMS compared with patients who had recently progressed to 'no longer benign' (NLB).
METHODS: A previously reported cohort of BMS (EDSS ≤3 at 20 years disease duration) were re-assessed 25-30 years post-onset. Patients remaining benign (EDSS ≤3 at re-assessment) were compared with those NLB for: depression (Beck Depression Inventory), fatigue (Modified Fatigue Impact Scale), health-related quality of life (MSQoL-54), cognition (Rao's Neuropsychological Screening Battery), and employment status.
RESULTS: A total of 75% (66/88) of the original cohort were located. A total of 61 patients were re-assessed. Twenty-five patients (41%) had progressed in EDSS and were NLB. Compared with benign patients, those NLB were more likely to have: significant fatigue (15/36 [42%] vs. 18/25 [72%], p = 0.019); poorer physical functioning (mean MSQoL-54 = 67.30 vs. 50.89, p = 0.002); an MS-related negative change in employment status (13/36 [36%] vs. 21/25 [84%], p < 0.0001) and cognitive impairment (3/28 [11%] vs. 5/19 [26%]; trend only, p = 0.317). Depression and mental health quality if life differed little between the benign and NLB patients (p > 0.6).
CONCLUSIONS: Despite remaining benign for 20 years, a significant proportion of patients progressed with further follow up. While neither depression nor patient-reported mental health quality of life was associated with EDSS progression, patients with longstanding 'benign' MS (EDSS ≤3 for 25+ years) had less fatigue, better physical quality of life and employment outcomes and infrequent cognitive impairment. Remaining benign over the long term, as defined by the EDSS, carried some advantages beyond ambulation.

Entities:  

Mesh:

Year:  2011        PMID: 21677023     DOI: 10.1177/1352458511410343

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  8 in total

Review 1.  Benign multiple sclerosis: does it exist?

Authors:  Jorge Correale; María C Ysrraelit; Marcela P Fiol
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

2.  Social, societal, and economic burden of mal de debarquement syndrome.

Authors:  Allison Macke; Andrew LePorte; Brian C Clark
Journal:  J Neurol       Date:  2012-01-10       Impact factor: 4.849

3.  Quality of life and patient preferences: identification of subgroups of multiple sclerosis patients.

Authors:  Rosalba Rosato; Silvia Testa; Alessandra Oggero; Giorgia Molinengo; Antonio Bertolotto
Journal:  Qual Life Res       Date:  2015-02-26       Impact factor: 4.147

4.  Tract-specific white matter correlates of fatigue and cognitive impairment in benign multiple sclerosis.

Authors:  Maxim Bester; Mariana Lazar; Maria Petracca; James S Babb; Joseph Herbert; Robert I Grossman; Matilde Inglese
Journal:  J Neurol Sci       Date:  2013-05-01       Impact factor: 3.181

Review 5.  Psychiatric manifestations in cerebrotendinous xanthomatosis.

Authors:  M J Fraidakis
Journal:  Transl Psychiatry       Date:  2013-09-03       Impact factor: 6.222

6.  Factors associated with benign multiple sclerosis in the New York State MS Consortium (NYSMSC).

Authors:  Robert Zivadinov; Diane L Cookfair; Lauren Krupp; Aaron E Miller; Neil Lava; Patricia K Coyle; Andrew D Goodman; Burk Jubelt; Michael Lenihan; Joseph Herbert; Malcolm Gottesman; David H Snyder; Brian R Apatoff; Barbara E Teter; Allan B Perel; Frederick Munschauer; Bianca Weinstock-Guttman
Journal:  BMC Neurol       Date:  2016-07-15       Impact factor: 2.474

7.  Impairment and restrictions in possibly benign multiple sclerosis.

Authors:  Laura Melanie Schaefer; Jana Poettgen; Anja Fischer; Stefan Gold; Jan-Patrick Stellmann; Christoph Heesen
Journal:  Brain Behav       Date:  2019-03-18       Impact factor: 2.708

8.  Optical coherence tomography and T cell gene expression analysis in patients with benign multiple sclerosis.

Authors:  John Soltys; Qin Wang; Yang Mao-Draayer
Journal:  Neural Regen Res       Date:  2017-08       Impact factor: 5.135

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.